U.S. Earnings Preview: Before Market Open May 12

Dow Jones05-12 17:31

This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results before the market opens.

$Aramark(ARMK-W)$'s second-quarter EPS is forecast at 43 cents, compared with 23 cents in the prior-year period. Adjusted EPS is forecast at 47 cents.

Zebra Technologies Corp.'s first-quarter EPS is forecast at $2.81, compared with $2.62 in the prior-year period. Adjusted EPS is forecast at $4.25.

Middleby Corp.'s first-quarter EPS is forecast at $2.13, compared with $1.99 in the prior-year period. Adjusted EPS is forecast at $2.32.

Legend Biotech Corp. ADR's first-quarter EPS is forecast at 1 cent, compared with a loss of 54 cents in the prior-year period.

Under Armour Inc.'s fourth-quarter EPS is forecast at a loss of 7 cents, compared with a loss of 16 cents in the prior-year period. Adjusted EPS is forecast at a loss of 2 cents.

Ducommun Inc.'s first-quarter EPS is forecast at 57 cents, compared with 69 cents in the prior-year period. Adjusted EPS is forecast at 68 cents.

Vestis Corp.'s second-quarter EPS is forecast at $0.00, compared with a loss of 21 cents in the prior-year period. Adjusted EPS is forecast at 8 cents.

MeiraGTx Holdings PLC's first-quarter EPS is forecast at a loss of 17 cents, compared with a loss of 51 cents in the prior-year period. Adjusted EPS is forecast at a loss of 61 cents.

Vishay Precision Group Inc.'s first-quarter EPS is forecast at a loss of 2 cents. Adjusted EPS is forecast at 0 cents.

Janus International Group Inc.'s first-quarter EPS is forecast at 6 cents, compared with 8 cents in the prior-year period. Adjusted EPS is forecast at 9 cents.

Arvinas Inc.'s first-quarter EPS is forecast at a loss of 92 cents, compared with net income of $1.14 per share in the prior-year period.

Candel Therapeutics Inc.'s first-quarter EPS is forecast at a loss of 24 cents, compared with net income of 13 cents per share in the prior-year period. Adjusted EPS is forecast at a loss of 30 cents.

XOMA Royalty Corp.'s first-quarter EPS is forecast at 17 cents, compared with 6 cents in the prior-year period.

Lifeway Foods Inc.'s first-quarter EPS is forecast at 30 cents, compared with 23 cents in the prior-year period.

Zentalis Pharmaceuticals Inc.'s first-quarter EPS is forecast at a loss of 48 cents, compared with a loss of 67 cents in the prior-year period.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

(END) Dow Jones Newswires

May 12, 2026 05:31 ET (09:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

U.S. Earnings Preview: Before Market Open May 12

At the request of the copyright holder, you need to log in to view this content

Comments